Prado Luan G, Nagy Laura E
Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.
Department of Molecular Medicine, Case Western Reserve University, Cleveland, Ohio.
Semin Liver Dis. 2024 Nov;44(4):510-522. doi: 10.1055/s-0044-1795143. Epub 2024 Nov 28.
This review aims to summarize recent research using animal models, cell models, and human data regarding the role of complement in liver disease. Complement is part of the innate immune system and was initially characterized for its role in control of pathogens. However, evidence now indicates that complement also plays an important role in the response to cellular injury that is independent of pathogens. The liver is the main organ responsible for producing circulating complement. In response to liver injury, complement is activated and likely plays a dual role, both contributing to and protecting from injury. In uncontrolled complement activation, cell injury and liver inflammation occur, contributing to progression of liver disease. Complement activation is implicated in the pathogenesis of multiple liver diseases, including alcohol-associated liver disease, metabolic dysfunction-associated steatotic liver disease, fibrosis and cirrhosis, hepatocellular carcinoma, and autoimmune hepatitis. However, the mechanisms by which complement is overactivated in liver diseases are still being unraveled.
本综述旨在总结近期利用动物模型、细胞模型和人类数据开展的关于补体在肝脏疾病中作用的研究。补体是固有免疫系统的一部分,最初因其在控制病原体方面的作用而被描述。然而,现在有证据表明,补体在对与病原体无关的细胞损伤的反应中也发挥着重要作用。肝脏是负责产生循环补体的主要器官。对肝损伤的反应中,补体被激活,可能发挥双重作用,既促成损伤,又保护机体免受损伤。在补体不受控制的激活中,会发生细胞损伤和肝脏炎症,促进肝脏疾病的进展。补体激活与多种肝脏疾病的发病机制有关,包括酒精性肝病、代谢功能障碍相关脂肪性肝病、纤维化和肝硬化、肝细胞癌以及自身免疫性肝炎。然而,补体在肝脏疾病中过度激活的机制仍在探索之中。